REFRACTORY NEUROBLASTOMA
Clinical trials for REFRACTORY NEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY NEUROBLASTOMA trials appear
Sign up with your email to follow new studies for REFRACTORY NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancers: first test of 'Living Drug' therapy
Disease control Recruiting nowThis is the first time researchers are testing a new type of cell therapy called GPC2 CAR T in children. The trial aims to find a safe dose for kids with advanced neuroblastoma or metastatic retinoblastoma that has come back or hasn't responded to all other standard treatments. D…
Matched conditions: REFRACTORY NEUROBLASTOMA
Phase: PHASE1 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for kids with tough cancers: first test of donor cell therapy
Disease control Recruiting nowThis is a first-in-human safety study testing a new type of donor immune cell therapy for children whose neuroblastoma or osteosarcoma has come back or hasn't responded to standard treatments. The main goal is to find the safest dose of these cells when given alongside a combinat…
Matched conditions: REFRACTORY NEUROBLASTOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for kids with incurable cancer: first trial of groundbreaking cell therapy begins
Disease control Recruiting nowThis is the first-ever study in people to test a new type of CAR-T cell therapy called PHOX2B PC-CAR T for children with advanced, high-risk neuroblastoma that has come back or not responded to other treatments. The main goal is to find a safe dose and see if the treatment can be…
Matched conditions: REFRACTORY NEUROBLASTOMA
Phase: PHASE1 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New immune cell therapy tested for tough childhood cancer
Disease control Recruiting nowThis early-stage trial is testing a new treatment for children and young adults whose high-risk neuroblastoma has come back or hasn't responded to standard treatments. Doctors will collect a patient's own immune cells, modify them in a lab to better target the cancer, and then in…
Matched conditions: REFRACTORY NEUROBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Roberto Chiarle • Aim: Disease control
Last updated Mar 09, 2026 14:27 UTC
-
New hope for kids with tough cancers: trial tests Double-Team drug strategy
Disease control Recruiting nowThis study is testing two different drug combinations to find safe doses and see if they can help control cancer in children and young adults whose solid tumors have come back or haven't responded to treatment. In the first part, participants will be assigned to receive either On…
Matched conditions: REFRACTORY NEUROBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 02, 2026 15:24 UTC